EU-LIFE

Building and promoting Excellence in Life Sciences in Europe
Building and promoting Excellence in Life Sciences in Europe

News

EU-LIFE Science Newsletter 3/2017

Latest News from EU-LIFE


Moving forward with FAIR data, the European Science Cloud, the future of scientific publishing, Research evaluation and altmetrics, Rewards and skills for the advancement of open science, citizen science.

EU-LIFE Science Newsletter 3/2017

News from the Institute for Molecular Medicine Finland (FIMM), Finland


Combinatorial therapies can tackle the drug resistance problem in cancer. Researchers at FIMM are developing novel informatics tools and pre-clinical testing platforms to facilitate the discovery of most promising targeted drug combinations among the exponentially increasing number of possibilities.

EU-LIFE Newsletter 3/2017

Latest News from EU-LIFE


R&I policy is like the fashion business: while users enjoy current outfit, experts are already fully into future seasons. This is to say that only mid-way of H2020, the next FP9 is already at the core of policy discussion.

EU-LIFE Science Newsletter 3/2017

News from the Institut Curie (IC), France


Many adult tissues renew terminally differentiated cell types. How are balanced numbers of cell populations are achieved? A new study from the Institut Curie (in press, EMBOJ) uncovers a lineage-intrinsic mechanism required for enteroendocrine cell fate specification during tissue homeostasis in the fly intestine.

EU-LIFE Science Newsletter 3/2017

News from the Biotech Research & Innovation Centre (BRIC), Denmark


The dynamics of tissues and how they become disrupted in disease remain largely unknown. In a cross-disciplinary study, BRIC researchers together with other researchers at the University of Copenhagen investigated the correlation between the dynamics of cancer cell division and invasion. The study was published in Scientific Reports, providing new insights into how tissue dynamics are altered when homeostasis is challenged.

EU-LIFE Science Newsletter 3/2017

Latest News from the Centre for Genomic Regulation (CRG), Spain


28 different kinds of collagens constitute about 25% of our dry body weight and are the main ingredients of connective tissue. More than 1,000 mutations in collagens have been identified in a variety of human diseases. CRG scientists explain their latest results on understanding how collagens are secreted and exported in the cell.

EU-LIFE Science Newsletter 3/2017

News from the Netherlands Cancer Institute (NKI), The Netherlands


Our cells - and ultimately our entire body - are governed by genes, the functional units of our DNA. Gene expression rests on two very important processes, called transcription and translation. The research group of Reuven Agami from the Netherlands Cancer Institute (NKI) now shows a link between these two processes.

EU-LIFE Science Newsletter 3/2016

Collaboration News from VIB and CEITEC


Throughout evolution, mammalian viruses co-evolved with their hosts and developed effective ways to counter and evade the antiviral responses of the host immune system. An international team - including VIB and CEITEC scientists - unraveled a molecular strategy used by the widespread parapox Orf virus to counter the mammalian immune system.

EU-LIFE Science Newsletter 3/2016

Collaboration News from CRG, MDC, BI and CEITEC


ORION is a new collaborative European project to explore ways in which research and funding organizations in life sciences and biomedicine can open up the way they fund, organize and do research. CRG, MDC, BI and CEITEC, each leading a work package, are among the nine partners in the project.

EU-LIFE Science Newsletter 3/2017

Community News from the Biotech Research & Innovation Centre (BRIC), Denmark


​To bring science closer to high school students in Denmark and provide outreach opportunities for our many Marie S. Curie funded fellows, BRIC hosted its first hands-on training for high school students writing their 3rd year project (SRP) in life sciences back in November 2016. The topic was cancer treatment.